Nike's NFL Partnership Gets Major Boost With 10-Year Deal, Stock Gains
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 11 2024
0mins
Source: Benzinga
Nike and NFL Partnership: Nike, Inc. has extended its partnership with the NFL for another 10 years, continuing as the exclusive provider of uniforms and apparel for all 32 teams, focusing on innovation and player safety.
Stock Performance: Despite the positive news regarding the partnership, Nike's stock (NKE) has seen a decline of over 33% in the past year, although it is currently trading higher by 2.50%.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy NKE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on NKE
Wall Street analysts forecast NKE stock price to rise
21 Analyst Rating
14 Buy
7 Hold
0 Sell
Moderate Buy
Current: 51.240
Low
62.00
Averages
76.11
High
110.00
Current: 51.240
Low
62.00
Averages
76.11
High
110.00
About NKE
NIKE, Inc. is engaged in the designing, marketing and distributing of athletic footwear, apparel, equipment and accessories and services for sports and fitness activities. The Company's operating segments include North America; Europe, Middle East & Africa (EMEA); Greater China; and Asia Pacific & Latin America (APLA). It sells a line of equipment and accessories under the NIKE Brand name, including bags, socks, sport balls, eyewear, timepieces, digital devices, bats, gloves, protective equipment and other equipment designed for sports activities. It also designs products specifically for the Jordan Brand and Converse. The Jordan Brand designs, distributes and licenses athletic and casual footwear, apparel and accessories predominantly focused on basketball performance and culture using the Jumpman trademark. The Company also designs, distributes and licenses casual sneakers, apparel and accessories under the Chuck Taylor, All Star, One Star, Star Chevron and Jack Purcell trademarks.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Nike, Inc. Q3 Earnings Forecast
- Earnings Release Date: Nike, Inc. is set to release its Q3 earnings on March 31, generating significant anticipation in the market as it is expected to reveal the company's performance amid current economic conditions.
- Earnings Expectations: Analysts forecast an EPS of 28 cents and revenue of $11.23 billion for Q3, reflecting strong consumer demand for the Nike brand and confidence in the company's market position.
- Consistent Outperformance: Nike has exceeded EPS estimates for 10 consecutive quarters, demonstrating the company's resilience in a competitive market and effective operational strategies, which further solidifies investor confidence in its future growth.
- Market Reaction: As the earnings report approaches, investor interest in Nike is rising, likely to positively impact its stock price, especially given the company's ongoing demonstration of strong profitability and market leadership.
See More
Nike Faces Turnaround Challenges and Opportunities
- Executive Change: Nike appointed Elliott Hill as the new CEO in Fall 2024, aiming to rebuild relationships with partners to drive growth; however, increasing market competition and changing consumer behaviors pose significant challenges to this goal.
- Weak Performance: For the six months ending November 30, 2025, Nike's revenue grew only 1% while cost of sales rose by 6%, leading to a 31% drop in profits, indicating that even under new leadership, the company struggles to reverse its fortunes, highlighting the difficulties of the turnaround path.
- Significant Stock Decline: Over the past five years, Nike's stock has plummeted by 61%, currently trading at a price-to-earnings ratio of 30, with a forward P/E expected to drop to 20, but analysts remain cautious about the company's turnaround progress, which may impact future stock performance.
- Investor Confidence Issues: Despite Nike's iconic brand, current economic conditions and market uncertainties have weakened investor confidence in its growth potential, suggesting a wait-and-see approach is prudent until clearer turnaround results emerge.
See More
Multiple Companies Set to Report Earnings
- Nike Earnings Forecast: Nike (NKE) is expected to report an earnings per share of $0.29 for the quarter ending February 28, 2026, representing a 46.30% decrease compared to the same quarter last year, indicating increased competitive pressure despite beating expectations consistently over the past year.
- PVH Earnings Outlook: PVH is forecasting an earnings per share of $3.30 for the quarter ending January 31, 2026, reflecting a modest 0.92% increase year-over-year, demonstrating its stable market position as it has consistently exceeded market expectations in the past year.
- RH Earnings Growth: RH anticipates an earnings per share of $2.21 for the quarter ending January 31, 2026, marking a significant 39.87% year-over-year increase, showcasing strong business growth potential that may attract more investor interest.
- nCino Earnings Prediction: nCino expects an earnings per share of $0.06 for the quarter ending January 31, 2026, representing a remarkable 250.00% increase compared to the same quarter last year, which could help restore market confidence after previous underperformance.
See More
Market Rallies on Signs of Iran Conflict De-escalation
- Market Rally: The S&P 500 surged over 2% on Tuesday amid signs of potential de-escalation in the Iran conflict, reflecting investor optimism, although caution is still warranted regarding this signal.
- Eli Lilly Acquisition: Eli Lilly announced its acquisition of Centessa Pharmaceuticals for up to $7.8 billion, focusing on new treatments for excessive daytime sleepiness, with peak sales for its key asset cleminorexton projected to exceed $3 billion, further solidifying Lilly's position in neuroscience.
- Novo Nordisk Competition: Novo Nordisk launched a subscription program to lower prices on Wegovy, aiming to reclaim market share from Eli Lilly, which leads in the GLP-1 category, highlighting the need for continuous innovation to maintain competitive advantage.
- Analyst Ratings: Truist initiated coverage of Corning with a hold rating and a $125 price target, expressing optimism about its optical business growth while raising concerns over current valuations, indicating a cautious market outlook on Corning's future growth potential.
See More
Surge in Options Trading Volume for Nike and Broadcom
- Nike Options Volume: Today, Nike options have reached a trading volume of 77,752 contracts, equivalent to approximately 7.8 million shares, representing 49.3% of its average daily trading volume over the past month, indicating a significant increase in market interest in Nike stock.
- High Volume Put Options: Among Nike's options, the $47 strike put option expiring on April 2, 2026, has seen particularly high activity with 3,787 contracts traded so far, representing about 378,700 underlying shares, reflecting investor expectations of potential downward pressure on the stock price.
- Broadcom Options Volume: Similarly, Broadcom's options trading volume has been robust, reaching 146,999 contracts today, equivalent to approximately 14.7 million shares, which is 49% of its average daily trading volume over the past month, showcasing strong market interest in Broadcom.
- High Volume Call Options: The $315 strike call option for Broadcom has also shown significant activity today, with 11,173 contracts traded, representing about 1.1 million underlying shares, indicating investor confidence in the potential for Broadcom's stock price to rise.
See More
Snap Shares Surge on Activist Investor Proposal
- Snap Share Surge: Shares of social media platform Snap surged 12% after activist investor Irenic disclosed a 2.5% stake and proposed shutting down its augmented reality Specs business to boost share prices, indicating strong market confidence in its strategic direction.
- FactSet Earnings Beat: FactSet's adjusted earnings for Q2 came in at $4.46 per share, exceeding the consensus estimate of $4.38, while the company raised its full-year guidance to an expected adjusted earnings range of $17.25 to $17.75 per share, reflecting robust market performance and growth potential.
- Symbotic Strategic Agreement: Robotics company Symbotic's stock jumped nearly 5% following a strategic agreement to provide warehouse automation capabilities at Associated Wholesale Grocers' Gulf Coast Division Support Center in Louisiana, highlighting its expansion in logistics automation and growing market demand.
- Apellis Pharmaceuticals Stock Doubles: Shares of Apellis Pharmaceuticals soared 135% after Biogen announced it would acquire the company for $5.6 billion in cash, enhancing Biogen's portfolio in immunology and rare diseases, showcasing strong market approval for the deal.
See More
Nike, Inc. Q3 Earnings Forecast
- Earnings Release Date: Nike, Inc. is set to release its Q3 earnings on March 31, generating significant anticipation in the market as it is expected to reveal the company's performance amid current economic conditions.
- Earnings Expectations: Analysts forecast an EPS of 28 cents and revenue of $11.23 billion for Q3, reflecting strong consumer demand for the Nike brand and confidence in the company's market position.
- Consistent Outperformance: Nike has exceeded EPS estimates for 10 consecutive quarters, demonstrating the company's resilience in a competitive market and effective operational strategies, which further solidifies investor confidence in its future growth.
- Market Reaction: As the earnings report approaches, investor interest in Nike is rising, likely to positively impact its stock price, especially given the company's ongoing demonstration of strong profitability and market leadership.
See More
Nike Faces Turnaround Challenges and Opportunities
- Executive Change: Nike appointed Elliott Hill as the new CEO in Fall 2024, aiming to rebuild relationships with partners to drive growth; however, increasing market competition and changing consumer behaviors pose significant challenges to this goal.
- Weak Performance: For the six months ending November 30, 2025, Nike's revenue grew only 1% while cost of sales rose by 6%, leading to a 31% drop in profits, indicating that even under new leadership, the company struggles to reverse its fortunes, highlighting the difficulties of the turnaround path.
- Significant Stock Decline: Over the past five years, Nike's stock has plummeted by 61%, currently trading at a price-to-earnings ratio of 30, with a forward P/E expected to drop to 20, but analysts remain cautious about the company's turnaround progress, which may impact future stock performance.
- Investor Confidence Issues: Despite Nike's iconic brand, current economic conditions and market uncertainties have weakened investor confidence in its growth potential, suggesting a wait-and-see approach is prudent until clearer turnaround results emerge.
See More
Multiple Companies Set to Report Earnings
- Nike Earnings Forecast: Nike (NKE) is expected to report an earnings per share of $0.29 for the quarter ending February 28, 2026, representing a 46.30% decrease compared to the same quarter last year, indicating increased competitive pressure despite beating expectations consistently over the past year.
- PVH Earnings Outlook: PVH is forecasting an earnings per share of $3.30 for the quarter ending January 31, 2026, reflecting a modest 0.92% increase year-over-year, demonstrating its stable market position as it has consistently exceeded market expectations in the past year.
- RH Earnings Growth: RH anticipates an earnings per share of $2.21 for the quarter ending January 31, 2026, marking a significant 39.87% year-over-year increase, showcasing strong business growth potential that may attract more investor interest.
- nCino Earnings Prediction: nCino expects an earnings per share of $0.06 for the quarter ending January 31, 2026, representing a remarkable 250.00% increase compared to the same quarter last year, which could help restore market confidence after previous underperformance.
See More
Market Rallies on Signs of Iran Conflict De-escalation
- Market Rally: The S&P 500 surged over 2% on Tuesday amid signs of potential de-escalation in the Iran conflict, reflecting investor optimism, although caution is still warranted regarding this signal.
- Eli Lilly Acquisition: Eli Lilly announced its acquisition of Centessa Pharmaceuticals for up to $7.8 billion, focusing on new treatments for excessive daytime sleepiness, with peak sales for its key asset cleminorexton projected to exceed $3 billion, further solidifying Lilly's position in neuroscience.
- Novo Nordisk Competition: Novo Nordisk launched a subscription program to lower prices on Wegovy, aiming to reclaim market share from Eli Lilly, which leads in the GLP-1 category, highlighting the need for continuous innovation to maintain competitive advantage.
- Analyst Ratings: Truist initiated coverage of Corning with a hold rating and a $125 price target, expressing optimism about its optical business growth while raising concerns over current valuations, indicating a cautious market outlook on Corning's future growth potential.
See More
Surge in Options Trading Volume for Nike and Broadcom
- Nike Options Volume: Today, Nike options have reached a trading volume of 77,752 contracts, equivalent to approximately 7.8 million shares, representing 49.3% of its average daily trading volume over the past month, indicating a significant increase in market interest in Nike stock.
- High Volume Put Options: Among Nike's options, the $47 strike put option expiring on April 2, 2026, has seen particularly high activity with 3,787 contracts traded so far, representing about 378,700 underlying shares, reflecting investor expectations of potential downward pressure on the stock price.
- Broadcom Options Volume: Similarly, Broadcom's options trading volume has been robust, reaching 146,999 contracts today, equivalent to approximately 14.7 million shares, which is 49% of its average daily trading volume over the past month, showcasing strong market interest in Broadcom.
- High Volume Call Options: The $315 strike call option for Broadcom has also shown significant activity today, with 11,173 contracts traded, representing about 1.1 million underlying shares, indicating investor confidence in the potential for Broadcom's stock price to rise.
See More
Snap Shares Surge on Activist Investor Proposal
- Snap Share Surge: Shares of social media platform Snap surged 12% after activist investor Irenic disclosed a 2.5% stake and proposed shutting down its augmented reality Specs business to boost share prices, indicating strong market confidence in its strategic direction.
- FactSet Earnings Beat: FactSet's adjusted earnings for Q2 came in at $4.46 per share, exceeding the consensus estimate of $4.38, while the company raised its full-year guidance to an expected adjusted earnings range of $17.25 to $17.75 per share, reflecting robust market performance and growth potential.
- Symbotic Strategic Agreement: Robotics company Symbotic's stock jumped nearly 5% following a strategic agreement to provide warehouse automation capabilities at Associated Wholesale Grocers' Gulf Coast Division Support Center in Louisiana, highlighting its expansion in logistics automation and growing market demand.
- Apellis Pharmaceuticals Stock Doubles: Shares of Apellis Pharmaceuticals soared 135% after Biogen announced it would acquire the company for $5.6 billion in cash, enhancing Biogen's portfolio in immunology and rare diseases, showcasing strong market approval for the deal.
See More
